New Biomarker Candidates for Colon Cancer
Michael Schubert, PhD
New biomarker candidates may help determine which colon cancer patients are most likely to benefit from chemotherapy
Colon Cancer
Liquid Biopsy Not Effective for Colorectal Cancer Screening
American Gastroenterological Association
A blood test will be better than nothing, but may lead to more CRC cases and deaths than established screening tests
WHO’s Estimates Highlight Growing Global Cancer Burden
World Health Organization
The estimates report the disproportionate impact on low-resource settings and the lack of core financial health services
Vaccine Candidate Delays Relapse of KRAS-Mutated Cancers
University of Texas MD Anderson Cancer Center
All patients receiving the highest dose had significant T-cell responses, correlating with a significant reduction in risk of relapse
Antidiabetic Drug May Reduce Colorectal Cancer Incidence
Case Western Reserve University
Colorectal cancer is the second-leading cause of cancer mortality with 52,550 deaths per year
Treatment Combo Outperforms Standard-of-Care in Colorectal Cancer Trial
City of Hope
The novel therapeutic could provide a new option for patients with treatment-resistant KRAS gene mutation-positive colorectal cancer
New Guideline to Promote Health Equity in Canada
Canadian Medical Association Journal
16 recommendations to help people facing disadvantages and barriers to accessing health care
NIH Releases Annual Report to the Nation
National Institutes of Health
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Researchers Study Rare Genetic Condition to Tackle Colorectal Cancer
Mayo Clinic
Studying Familial Adenomatous Polyposis may lead to ways to prevent colorectal cancer in the general population
New Blood Test Could Spare Colon Cancer Patients from Unnecessary Chemotherapy
Walter and Eliza Hall Institute
The results of this landmark study could also revolutionize the development of new drug targets